559 related articles for article (PubMed ID: 30971473)
1. Nipah and Hendra Virus Glycoproteins Induce Comparable Homologous but Distinct Heterologous Fusion Phenotypes.
Bradel-Tretheway BG; Zamora JLR; Stone JA; Liu Q; Li J; Aguilar HC
J Virol; 2019 Jul; 93(13):. PubMed ID: 30971473
[TBL] [Abstract][Full Text] [Related]
2. Headless Henipaviral Receptor Binding Glycoproteins Reveal Fusion Modulation by the Head/Stalk Interface and Post-receptor Binding Contributions of the Head Domain.
Yeo YY; Buchholz DW; Gamble A; Jager M; Aguilar HC
J Virol; 2021 Sep; 95(20):e0066621. PubMed ID: 34288734
[TBL] [Abstract][Full Text] [Related]
3. Efficient reverse genetics reveals genetic determinants of budding and fusogenic differences between Nipah and Hendra viruses and enables real-time monitoring of viral spread in small animal models of henipavirus infection.
Yun T; Park A; Hill TE; Pernet O; Beaty SM; Juelich TL; Smith JK; Zhang L; Wang YE; Vigant F; Gao J; Wu P; Lee B; Freiberg AN
J Virol; 2015 Jan; 89(2):1242-53. PubMed ID: 25392218
[TBL] [Abstract][Full Text] [Related]
4. Third Helical Domain of the Nipah Virus Fusion Glycoprotein Modulates both Early and Late Steps in the Membrane Fusion Cascade.
Zamora JLR; Ortega V; Johnston GP; Li J; André NM; Monreal IA; Contreras EM; Whittaker GR; Aguilar HC
J Virol; 2020 Sep; 94(19):. PubMed ID: 32669342
[TBL] [Abstract][Full Text] [Related]
5. Novel Roles of the N1 Loop and N4 Alpha-Helical Region of the Nipah Virus Fusion Glycoprotein in Modulating Early and Late Steps of the Membrane Fusion Cascade.
Zamora JLR; Ortega V; Johnston GP; Li J; Aguilar HC
J Virol; 2021 Apr; 95(9):. PubMed ID: 33568505
[TBL] [Abstract][Full Text] [Related]
6. Novel Functions of Hendra Virus G N-Glycans and Comparisons to Nipah Virus.
Bradel-Tretheway BG; Liu Q; Stone JA; McInally S; Aguilar HC
J Virol; 2015 Jul; 89(14):7235-47. PubMed ID: 25948743
[TBL] [Abstract][Full Text] [Related]
7. Multiple Strategies Reveal a Bidentate Interaction between the Nipah Virus Attachment and Fusion Glycoproteins.
Stone JA; Vemulapati BM; Bradel-Tretheway B; Aguilar HC
J Virol; 2016 Dec; 90(23):10762-10773. PubMed ID: 27654290
[TBL] [Abstract][Full Text] [Related]
8. Prefusion stabilization of the Hendra and Langya virus F proteins.
Byrne PO; Blade EG; Fisher BE; Ambrozak DR; Ramamohan AR; Graham BS; Loomis RJ; McLellan JS
J Virol; 2024 Feb; 98(2):e0137223. PubMed ID: 38214525
[TBL] [Abstract][Full Text] [Related]
9. Novel Roles of the Nipah Virus Attachment Glycoprotein and Its Mobility in Early and Late Membrane Fusion Steps.
Ortega V; Zamora JLR; Monreal IA; Hoffman DT; Ezzatpour S; Johnston GP; Contreras EM; Vilchez-Delgado FJ; Aguilar HC
mBio; 2022 Jun; 13(3):e0322221. PubMed ID: 35506666
[TBL] [Abstract][Full Text] [Related]
10. Roles of Cholesterol in Early and Late Steps of the Nipah Virus Membrane Fusion Cascade.
Contreras EM; Johnston GP; Buchholz DW; Ortega V; Monreal IA; Zamora JLR; Cheung T; Aguilar HC
J Virol; 2021 Feb; 95(6):. PubMed ID: 33408170
[TBL] [Abstract][Full Text] [Related]
11. Nipah virus attachment glycoprotein stalk C-terminal region links receptor binding to fusion triggering.
Liu Q; Bradel-Tretheway B; Monreal AI; Saludes JP; Lu X; Nicola AV; Aguilar HC
J Virol; 2015 Feb; 89(3):1838-50. PubMed ID: 25428863
[TBL] [Abstract][Full Text] [Related]
12. N-glycans on Nipah virus fusion protein protect against neutralization but reduce membrane fusion and viral entry.
Aguilar HC; Matreyek KA; Filone CM; Hashimi ST; Levroney EL; Negrete OA; Bertolotti-Ciarlet A; Choi DY; McHardy I; Fulcher JA; Su SV; Wolf MC; Kohatsu L; Baum LG; Lee B
J Virol; 2006 May; 80(10):4878-89. PubMed ID: 16641279
[TBL] [Abstract][Full Text] [Related]
13. Receptor binding, fusion inhibition, and induction of cross-reactive neutralizing antibodies by a soluble G glycoprotein of Hendra virus.
Bossart KN; Crameri G; Dimitrov AS; Mungall BA; Feng YR; Patch JR; Choudhary A; Wang LF; Eaton BT; Broder CC
J Virol; 2005 Jun; 79(11):6690-702. PubMed ID: 15890907
[TBL] [Abstract][Full Text] [Related]
14. A functional henipavirus envelope glycoprotein pseudotyped lentivirus assay system.
Khetawat D; Broder CC
Virol J; 2010 Nov; 7():312. PubMed ID: 21073718
[TBL] [Abstract][Full Text] [Related]
15. Molecular determinants of antiviral potency of paramyxovirus entry inhibitors.
Porotto M; Carta P; Deng Y; Kellogg GE; Whitt M; Lu M; Mungall BA; Moscona A
J Virol; 2007 Oct; 81(19):10567-74. PubMed ID: 17652384
[TBL] [Abstract][Full Text] [Related]
16. Single amino acid changes in the Nipah and Hendra virus attachment glycoproteins distinguish ephrinB2 from ephrinB3 usage.
Negrete OA; Chu D; Aguilar HC; Lee B
J Virol; 2007 Oct; 81(19):10804-14. PubMed ID: 17652392
[TBL] [Abstract][Full Text] [Related]
17. Henipavirus membrane fusion and viral entry.
Aguilar HC; Iorio RM
Curr Top Microbiol Immunol; 2012; 359():79-94. PubMed ID: 22427111
[TBL] [Abstract][Full Text] [Related]
18. A Recombinant Chimeric Cedar Virus-Based Surrogate Neutralization Assay Platform for Pathogenic Henipaviruses.
Amaya M; Yin R; Yan L; Borisevich V; Adhikari BN; Bennett A; Malagon F; Cer RZ; Bishop-Lilly KA; Dimitrov AS; Cross RW; Geisbert TW; Broder CC
Viruses; 2023 Apr; 15(5):. PubMed ID: 37243163
[TBL] [Abstract][Full Text] [Related]
19. An antibody against the F glycoprotein inhibits Nipah and Hendra virus infections.
Dang HV; Chan YP; Park YJ; Snijder J; Da Silva SC; Vu B; Yan L; Feng YR; Rockx B; Geisbert TW; Mire CE; Broder CC; Veesler D
Nat Struct Mol Biol; 2019 Oct; 26(10):980-987. PubMed ID: 31570878
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of henipavirus infection by Nipah virus attachment glycoprotein occurs without cell-surface downregulation of ephrin-B2 or ephrin-B3.
Sawatsky B; Grolla A; Kuzenko N; Weingartl H; Czub M
J Gen Virol; 2007 Feb; 88(Pt 2):582-591. PubMed ID: 17251577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
